2024 News & Blog Articles Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells5th Apr 2024Cellecta’s CloneTracker XP™ was recently used in a study on oestrogen receptor-positive breast cancer relapse even after treatment with endocrine therapies (ET). Partnerships That Just...Click!4th Apr 2024 2BScientific invests into Cellexus International Limited2nd Apr 20242BScientific Limited today announces their investment into Cellexus International Limited. Lightning fast labelling with oYo from Alpha Thera12th Mar 2024 De-mystifying Proximity ligation assays6th Mar 2024 2BFound31st Jan 2024Seamless Solutions, Swift Results with 2BFound - Your Gateway to Essential Research Reagents.